<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Shore Baxter | Activity</title>
	<link>https://toxicdolls.com/members/camelshield6/activity/</link>
	<atom:link href="https://toxicdolls.com/members/camelshield6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Shore Baxter.</description>
	<lastBuildDate>Mon, 04 May 2026 16:22:51 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5a75fcc21fbdfae369c14b7246d6d2e1</guid>
				<title>Shore Baxter posted an update: primary non-small cell lung cancer patients. We selected [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/7562/</link>
				<pubDate>Sun, 22 Jun 2025 13:16:27 +0000</pubDate>

									<content:encoded><![CDATA[<p>primary non-small cell lung cancer patients. We selected prognostic factors for patients who had received chemotherapy to identify patients who were appropriate for chemotherapy.</p>
<p>Significant findings of the study A significant therapeutic effect of chemotherapy for second primary non-small cell lung cancer was proven through univariate Cox&hellip;<span class="activity-read-more" id="activity-read-more-7562"><a href="https://toxicdolls.com/activity-2/p/7562/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">25587a1a013faf6ce75d4ffc385c3d70</guid>
				<title>Shore Baxter posted an update: In the present review, we provide a current understanding of [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/5551/</link>
				<pubDate>Fri, 20 Jun 2025 16:08:48 +0000</pubDate>

									<content:encoded><![CDATA[<p>In the present review, we provide a current understanding of GSI mechanisms, discuss clinical performance to date, and suggest areas for future investigation that might maximize the utility of these agents. IMPLICATIONS FOR PRACTICE The performance of gamma secretase inhibitors (GSIs) in clinical trials generally has not reflected their&hellip;<span class="activity-read-more" id="activity-read-more-5551"><a href="https://toxicdolls.com/activity-2/p/5551/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">799d9f440b26535160425e0913f523bb</guid>
				<title>Shore Baxter became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/5520/</link>
				<pubDate>Fri, 20 Jun 2025 15:47:27 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>